Skip to main content
Compare · Acamprosate (Campral) vs Naltrexone (Vivitrol/ReVia) SAMHSA-verified · Updated May 2026

Acamprosate vs Naltrexone for Alcohol: Side-by-Side Comparison

Evidence-based comparison to help you choose the right treatment approach. Data sourced from SAMHSA, NIDA, and published clinical research.

(833) 567-5838
Free · Confidential · 24/7 Avg. 2-min response · no email capture
Save / Send to a loved one
Email
(833) 567-5838

Talk to a licensed specialist

Free & confidential 24/7 availability HIPAA-compliant No pressure

Key takeaways — Acamprosate vs Naltrexone for Alcohol

  • Placement decision is clinical, not preferential — the ASAM Criteria assesses withdrawal risk, home stability, and co-occurring conditions to match patient to program.
  • Both options are covered by most insurance at parity under the Mental Health Parity Act (MHPAEA).
  • Cost difference reflects intensity of care — see the side-by-side table below for specific ranges with Aetna, BCBS, Medicaid.
  • No single “best” option — it depends on substance, severity, and recovery-environment fit. Misplacement is the #1 reason for early treatment dropout.
  • Free 10-minute clinical assessment: call (833) 567-5838 — licensed placement specialist, no email capture, SAMHSA-verified directory.

Quick Verdict

You have you have already achieved abstinence and want to maintain it, experience post-acute withdrawal symptoms, or cannot take naltrexone.

You have you want to reduce cravings and drinking, prefer a monthly injection option, or are still actively drinking.

Not sure? Call (833) 567-5838 for a free clinical assessment.

How to actually choose between Acamprosate (Campral) and Naltrexone (Vivitrol/ReVia)

Three clinical variables drive every placement decision — not preference, not price, not convenience. First, withdrawal severity: for alcohol, benzodiazepines, and opioid dependence, unsupervised withdrawal can be medically dangerous — medical detox is almost always indicated first. For stimulants or cannabis, outpatient withdrawal is typically safe.

Second, home-environment stability. If home is sober, supportive, and low-trigger, outpatient or IOP typically works. If home is chaotic, triggering, or unsafe, residential removes the access problem and creates space for recovery. Third, co-occurring conditions: untreated depression, PTSD, or anxiety doubles relapse risk — needs integrated dual-diagnosis care regardless of setting.

Under the federal MHPAEA parity law, commercial insurers (Aetna, BCBS, Cigna, UnitedHealthcare) must cover both options at parity with medical care. Medicaid coverage varies by state — expansion states (CA, NY, CO, OR, WA, others) have broader access. Cost should rarely be the deciding factor — the clinical match determines outcome probability.

When to reassess during treatment

The initial placement is not a permanent verdict. Clinicians reassess weekly during the first month and whenever treatment milestones are hit. A patient starting in detox typically steps down to residential, then to IOP, then to standard outpatient + sober living over 6 to 12 months. Stepping up (not down) is also common — if outpatient isn’t holding, residential becomes appropriate. Flexibility is the norm.

See the full directory for all 21,568 SAMHSA-verified centers offering both options, or browse by state to narrow to your geography. Every listing shows accepted insurance, level-of-care offerings, and accreditation status, and connects directly to the facility’s own phone — or to our (833) 567-5838 placement helpline if you want a clinician to filter for you.

Head-to-Head Comparison

How It Works
Acamprosate (Campral)
Restores brain chemical balance (GABA/glutamate)
Naltrexone (Vivitrol/ReVia)
Blocks opioid receptors, reduces reward from drinking
When to Start
Acamprosate (Campral)
After achieving abstinence
Naltrexone (Vivitrol/ReVia)
Can start while still drinking
Administration
Acamprosate (Campral)
2 pills, 3 times daily
Naltrexone (Vivitrol/ReVia)
Daily pill or monthly injection (Vivitrol)
Main Benefit
Acamprosate (Campral)
Maintains abstinence, reduces PAWS
Naltrexone (Vivitrol/ReVia)
Reduces cravings and heavy drinking days
Side Effects
Acamprosate (Campral)
Diarrhea (most common), nausea
Naltrexone (Vivitrol/ReVia)
Nausea, headache, injection site reactions
Liver Concerns
Acamprosate (Campral)
Safe for liver disease
Naltrexone (Vivitrol/ReVia)
Requires liver function monitoring
Opioid Use
Acamprosate (Campral)
No interaction
Naltrexone (Vivitrol/ReVia)
Cannot use opioids (blocks them)
Cost/Month
Acamprosate (Campral)
$150-$300 (generic available)
Naltrexone (Vivitrol/ReVia)
$50 (oral) / $1,000-$1,500 (Vivitrol)
Insurance
Acamprosate (Campral)
Covered (generic available)
Naltrexone (Vivitrol/ReVia)
Covered (Vivitrol may need prior auth)
Evidence Strength
Acamprosate (Campral)
Strong (European studies)
Naltrexone (Vivitrol/ReVia)
Strong (US studies)

Key Differences Explained

Acamprosate and naltrexone are both FDA-approved medications for alcohol use disorder, but they work through completely different mechanisms and serve different clinical purposes.

Acamprosate (Campral) works by restoring the balance of brain chemicals (GABA and glutamate) disrupted by chronic alcohol use. It's most effective for people who have already stopped drinking and want to maintain abstinence. It reduces the post-acute withdrawal symptoms — anxiety, insomnia, restlessness — that drive early relapse.

Naltrexone blocks opioid receptors in the brain, reducing the pleasurable effects of alcohol. It can be taken as a daily pill (ReVia) or monthly injection (Vivitrol). Unlike acamprosate, naltrexone can be started while you're still drinking — it reduces heavy drinking days and cravings.

Can You Take Both?

Yes. The COMBINE study (the largest alcohol medication trial ever) found that combining naltrexone with behavioral therapy produced the best outcomes. Adding acamprosate didn't significantly improve results in this US study, though European trials showed stronger acamprosate effects. Some clinicians prescribe both for patients with severe alcohol dependence.

What About Disulfiram?

A third option, disulfiram (Antabuse), works through aversion — making you violently ill if you drink. It's effective for highly motivated patients but has compliance challenges.

Not Sure Which Is Right for You?

Our treatment specialists can assess your situation and recommend the right level of care. Free, confidential, 24/7.

(833) 567-5838

Frequently Asked Questions

Which medication is more effective for alcohol addiction?
Neither is clearly superior overall. Naltrexone is better for reducing heavy drinking and cravings. Acamprosate is better for maintaining complete abstinence once achieved. The COMBINE study favored naltrexone + therapy, but individual response varies. Your doctor should choose based on your specific situation.
Can I take acamprosate if I have liver problems?
Yes — this is acamprosate's major advantage. It's processed by the kidneys, not the liver, making it safe for patients with alcohol-related liver disease. Naltrexone requires liver function monitoring and may not be suitable for significant liver damage.
How long do I need to take these medications?
Most guidelines recommend at least 3-12 months, with some patients benefiting from longer treatment. Like medications for high blood pressure, stopping too early often leads to return of symptoms. Discuss duration with your prescriber.
What if I relapse while taking the medication?
Relapse doesn't mean the medication isn't working. Continue taking it — both medications reduce the severity and duration of relapse episodes. Tell your prescriber so they can adjust the treatment plan.
How do I decide which option fits my situation?
Three clinical variables drive placement: withdrawal risk (daily alcohol/benzo/opioid use usually requires medical detox first), home environment stability (triggering home → residential; stable home → IOP or outpatient), co-occurring mental health (depression, PTSD, anxiety → integrated dual-diagnosis care). Run the 5-min treatment quiz or call (833) 567-5838 for a 10-minute clinical assessment.
Does insurance cover both options equally?
Under the MHPAEA parity rule, insurers must cover SUD care at parity with medical/surgical care. What varies is pre-authorization, in-network provider lists, and day limits. Our placement team verifies your specific plan in under 5 minutes. Compare 10 major carriers.
What if my first choice does not work?
NIDA treats SUD as a chronic condition — 40–60% relapse rate is typical (comparable to diabetes and hypertension), and not treatment failure. If outpatient is not providing enough structure, clinicians step up to IOP or residential. If a specific MAT medication has side effects, they switch (methadone → buprenorphine, or add naltrexone). Call (833) 567-5838 to reassess and step up care.
How do I talk to a loved one about which fits?
Research supports CRAFT (Community Reinforcement and Family Training) over confrontational interventions. Our Family guide to addiction & recovery walks through CRAFT basics, boundaries, and conversation scripts. The share buttons on this page also let you send the exact comparison via WhatsApp, SMS, email, or Signal — often easier than starting a conversation cold.

Last updated: May 20, 2026 · Sources: SAMHSA, NIDA, ASAM

Was this comparison helpful?

Your feedback stays on your device — no tracker.

Talk to a specialist

Help someone — share this page

Free information, no signup required.

RehabFlow Placement Helpline

Need help finding the right program?

Free, confidential, 24/7. A licensed placement specialist will filter SAMHSA-verified centers by your insurance, preferred level of care, and location in under 10 minutes.

  • SAMHSA-verified directory
  • Licensed placement specialists
  • No email capture
  • Insurance check in 5 min

Call now · free · 24/7

Helpline (833) 567-5838

Avg. 2-min response · 42 CFR Part 2 privacy · we do not sell caller data.

Published by RehabFlow
SAMHSA-sourced directory · May 2026

Listings are sourced from the SAMHSA Behavioral Health Treatment Services Locator and cross-checked against public CDC and NIDA data. This page is informational, not medical advice — see our editorial policy for how we verify and update facts.

SAMHSA-verified data
Clinically reviewed
Updated May 2026
Editorial Policy ›
21,568 SAMHSA-verified centers · updated monthly